Colgate-Palmolive (India) (500830) Q4 05/06 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 05/06 earnings summary
19 Oct, 2026Executive summary
FY06 sales rose 17% to ₹1,124.19 crore; net profit reached a record ₹137.60 crore, up 21% YoY despite ₹24.04 crore of impairment, accelerated depreciation and investment diminution charges.
Consolidated revenue was ₹1,153.18 crore and consolidated PAT ₹140.04 crore; consolidated EPS was ₹10.30.
Financial highlights
Standalone total revenue was ₹1,149.80 crore vs ₹998.45 crore; PBT was ₹187.88 crore vs ₹178.14 crore, and PAT was ₹137.60 crore vs ₹113.29 crore.
Sales excluding excise duty were ₹1,124.19 crore vs ₹964.22 crore; other income declined to ₹25.61 crore from ₹34.23 crore.
Tax provision fell to ₹50.28 crore from ₹64.85 crore; FY06 earnings included ₹24.04 crore for impairment, accelerated depreciation and Nepal subsidiary investment diminution.
Operating cash flow was ₹184.60 crore vs ₹115.34 crore; cash and cash equivalents closed at ₹87.97 crore vs ₹56.14 crore.
Outlook and guidance
The toothpaste market opportunity and low per-capita usage underpin expectations for continued dentifrice market growth; planned drivers include innovation, marketing and market expansion.
Baddi toothpaste facility commissioning was completed; production of different variants is planned to maximize capacity utilization and tax benefits.
Latest events from Colgate-Palmolive (India)
- Q2 sales rose 12.2%, gross margin reached 69.6%, and adjusted PAT grew 5.5%.500830
Q2 26/27 - Sales grew 16.5%, but excise-related inventory costs constrained profit growth.500830
Q4 96/97 - Sales advanced amid sluggish demand as strategic investments and product launches expanded.500830
Q4 97/98 - Profit fell amid weak demand, while product launches and capacity expansion positioned growth.500830
Q4 98/99 - Sales rose 12% and adjusted profit 23% despite a depressed FMCG market.500830
Q4 99/00 - Profit rose 27% despite falling sales as product renewal offset market headwinds.500830
Q4 02/03 - Sales and profit advanced on launches and cash generation despite weak demand.500830
Q4 00/01 - Profit rose 22% as price cuts revived toothpaste demand and capacity expansion advanced.500830
Q4 03/04 - Profit rose 12% on flat sales, despite a major depreciation charge.500830
Q4 01/02